Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Medivation Initiates Phase 2 Trial of MDV9300: Stock Rises 5.7%
Medivation Initiates Phase 2 Trial of MDV9300: Stock Rises 5.7%
Medivation Initiates Phase 2 Trial of MDV9300: Stock Rises 5.7%
Submitted by
admin
on December 26, 2015 - 8:46pm
Source:
Yahoo/Market Realist
News Tags:
Medivation
MDV9300
clinical trials
diffuse large B-cell lymphoma
Headline:
Medivation Initiates Phase 2 Trial of MDV9300: Stock Rises 5.7%
Do Not Allow Advertisers to Use My Personal information
